123 related articles for article (PubMed ID: 33378850)
1. In reply to the letter to the editor regarding "TGM6 variants in Parkinson's disease: clinical findings and functional evidence".
Chen K; Tan Y; Zhao YX
J Integr Neurosci; 2020 Dec; 19(4):739-740. PubMed ID: 33378850
[TBL] [Abstract][Full Text] [Related]
2. Letter to the editor regarding "TGM6 variants in Parkinson's disease: clinical findings and functional evidence".
Hall A; Quinn JP; Billingsley KJ
J Integr Neurosci; 2020 Dec; 19(4):735-737. PubMed ID: 33378849
[TBL] [Abstract][Full Text] [Related]
3.
Chen K; Lu Y; Peng F; Yu HL; Wu JY; Tan Y; Zhao YX
J Integr Neurosci; 2020 Mar; 19(1):51-64. PubMed ID: 32259886
[No Abstract] [Full Text] [Related]
4. Reply to the Letter to the Editor "The Microbiota in Parkinson's Disease: Ranking the Risk of Heart Disease".
Hirayama M; Ohno K
Ann Nutr Metab; 2022; 78(2):119-120. PubMed ID: 35042218
[No Abstract] [Full Text] [Related]
5. Reply to: 'Letter to the Editor on "Sex Differences in Parkinson's Disease Phenotype and Caregiving Disparities"'.
Antar T; Iwaki H; B Singleton A
Mov Disord; 2021 Feb; 36(2):527-528. PubMed ID: 33599005
[No Abstract] [Full Text] [Related]
6. Reply to letter to the editor "Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges".
Velisar A; Bronte-Stewart H
Brain Stimul; 2019; 12(5):1330-1331. PubMed ID: 31235368
[No Abstract] [Full Text] [Related]
7. Inflammatory Bowel Disease and Parkinson's Disease: A Reply to Letter to the Editor of Shih-Wei Lai.
Weimers P; Halfvarson J; Saunders-Pullman R; Ludvigsson JF; Peter I; Olén O; Burisch J
Inflamm Bowel Dis; 2019 Sep; 25(10):e127. PubMed ID: 31406980
[No Abstract] [Full Text] [Related]
8. Reply to letter to the editor "tDCS effect on cognitive performance in Parkinson's disease" by Biundo et al.
Cotelli M; Manenti R; Brambilla M; Borroni B
Mov Disord; 2016 Aug; 31(8):1253-5. PubMed ID: 27270985
[No Abstract] [Full Text] [Related]
9. In reply to the letter to the editor regarding "Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study".
Zenesini C; Baldin E; Vignatelli L; D'Alessandro R
J Neurol Sci; 2020 Jan; 408():116511. PubMed ID: 31732173
[No Abstract] [Full Text] [Related]
10. Reply to Letter to the Editor: 'Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson's disease: a randomised controlled trial'.
Pazzaglia C; Imbimbo I; Tranchita E; Minganti C; Ricciardi D; Monaco RL; Parisi A; Padua L
Physiotherapy; 2021 Mar; 110():88-89. PubMed ID: 32798048
[No Abstract] [Full Text] [Related]
11. "Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?" Letter to the editor reply.
Coon EA; Laughlin RS
J Headache Pain; 2012 Nov; 13(8):687. PubMed ID: 23054065
[No Abstract] [Full Text] [Related]
12. Letter to the Editor. Cell therapy for Parkinson's disease.
Schweitzer JS; Herrington TM; Kim KS; Carter BS
J Neurosurg; 2022 Feb; 136(6):1810-1811. PubMed ID: 35120329
[No Abstract] [Full Text] [Related]
13. Letter to the editor in response to the letter from the EPIPARK Study Group regarding the publication 'Progression of fatigue in Parkinson's disease - a 9-year follow-up' (Eur J Neurol 2021. doi:10.1111/ene.14520).
Ongre SO; Dalen I; Tysnes OB; Alves G; Herlofson K
Eur J Neurol; 2021 Jun; 28(6):e33-e34. PubMed ID: 33547699
[No Abstract] [Full Text] [Related]
14. Reply to letter: Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis.
Alves M; Caldeira D; Ferro JM; Ferreira JJ
Eur J Neurol; 2020 Feb; 27(2):e12. PubMed ID: 31710751
[No Abstract] [Full Text] [Related]
15. Letter to the Editor regarding "Parkinson's disease and hip fractures: Are complications and mortality rates increased?".
Gallardo-Molina N
Eur J Orthop Surg Traumatol; 2021 Jan; 31(1):199-200. PubMed ID: 32770404
[No Abstract] [Full Text] [Related]
16. Letter to the editor: Parkinson's disease and early subthalamotomy.
Guridi J; Obeso JA
J Neurosurg; 2015 Apr; 122(4):980-1. PubMed ID: 25679280
[No Abstract] [Full Text] [Related]
17. Reply to a Letter by Dr. Stefani and Colleagues on: "Auditory Dysfunction in Parkinson's Disease".
Jafari Z; Kolb BE; Mohajerani MH
Mov Disord; 2020 Jul; 35(7):1284-1285. PubMed ID: 32691907
[No Abstract] [Full Text] [Related]
18. Letter to the Editor Regarding "Statistical Shape Analysis of Subthalamic Nucleus in Patients with Parkinson's Disease".
Gilmore G; Murgai A; Jog M
World Neurosurg; 2019 Aug; 128():629. PubMed ID: 31675769
[No Abstract] [Full Text] [Related]
19. Reply to the Letter "What does characterize exercise guidelines for Parkinson's disease?".
Martignon C; Pedrinolla A; Ruzzante F; Giuriato G; Laginestra FG; Bouça-Machado R; Ferreira JJ; Tinazzi M; Schena F; Venturelli M
Aging Clin Exp Res; 2021 Mar; 33(3):677-678. PubMed ID: 33389712
[No Abstract] [Full Text] [Related]
20. Reply to letter: Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials.
Rodrigues TM; Castro Caldas A; Ferreira JJ
Parkinsonism Relat Disord; 2016 Aug; 29():123-4. PubMed ID: 27237107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
